Crossmark

Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank

Crossref DOI link: https://doi.org/10.1186/s12876-025-04079-4

Published Online: 2025-07-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feng, Qi

Izzi-Engbeaya, Chioma N.

Manousou, Pinelopi

Woodward, Mark
License Information

Text and Data Mining valid from 2025-07-31

Version of Record valid from 2025-07-31
More Information

Article History

Received: 15 April 2025

Accepted: 9 June 2025

First Online: 31 July 2025

Declarations

:

: We used UK Biobank data. UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. This approval means that researchers do not require separate ethical clearance and can operate under the RTB approval. All UK Biobank participants have provided consent to participate.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below